ITGB7 and neoplasm: ITGB7 was expressed in both metastatic subtypes and was significantly correlated (MBM: R = 0.51, p = 1.8e-06; EM: R = 0.69, p = 1.1e-09) with the tumor ́s immune scores (Fig. 2e).